The RAND study addresses the need for more sustainable and scalable ways to stimulate pharmaceutical innovation in response to a pandemic. The issue is considered both in the current context of the COVID-19 crisis and in the context of preventing other threats of infectious diseases. And it is not just about financial resources.

Many think tanks focus on studying the virus and its impact on economic, political, social and cultural processes in certain countries and in the world as a whole.

We have launched a new section – COVID-19: Research, where we monitor the leading research, analysis and statistics on Covid-19 in think tanks. We publish these materials so that our readers have access to quality analytics on those issues.